Current - 25 seconds ago

* About Us

* Portfolio

* Leadership

* News & Insights

* Contact

EN CH

Building the Future of Health Sciences

OrbiMed seeks to invest globally in world-class healthcare companies to help drive innovation, address unmet medical needs, and improve patient outcomes.

Providing tailored financing solutions and global team resources to help build

world-class healthcare companies.

From biopharmaceuticals to medical devices, digital health, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer, and more productive lives.

We have been investing globally for over 25 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 130 distinguished scientific, medical, investment, and other professionals manages approximately $17 billion across public and private company investments worldwide.

How We Invest

Meet Our Companies Driving Healthcare Innovation

Messenger RNA targeting to create life-saving therapeutics

ADARx is developing a proprietary RNA targeting platform, including oligonucleotides for inhibition, degradation, and editing, together with novel oligonucleotide delivery technologies.

Learn More

People with cancer can’t wait. Let’s go.

SpringWorks applies a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer.

Learn More

Pushing targeted oncology drug discovery to new heights

Treeline Biosciences is pursuing molecular targets in oncology that are validated but difficult to drug, leveraging its four pillars of drug discovery: mechanistic biology, medicinal chemistry, computational science, and structural biology and protein science.

Learn More

View All

$ 17 B

AUM

500 +

Portfolio

Companies

130 +

Total

Professionals

12

Global

Locations

130 +

Venture-backed

IPOs

News & Insights

View All

Orbimed News

OrbiMed Raises Over $4.3 Billion Across Private Investment Funds

Read More link

Orbimed News

Carl Gordon Featured on the Cambridge Associates Unseen Upside Podcast

Read More link

Portfolio News

Proteologix to be Acquired by Johnson & Johnson

Read More link

Orbimed News

OrbiMed Raises Over $4.3 Billion Across Private Investment Funds

Read More link

Orbimed News

Carl Gordon Featured on the Cambridge Associates Unseen Upside Podcast

Read More link

Portfolio News

Proteologix to be Acquired by Johnson & Johnson

Read More link

EN CH

© 2024 OrbiMed | Privacy Policy | Terms of Use

Manage Cookie Consent

We will collect and process your personal information when you visit our website or otherwise interact with us. Please see our Privacy Policy for more information. To the extent that China’s Personal Information Protection Law is applicable, you may contact us via PrivacyPolicy@OrbiMed.com to obtain additional details about our processing of your information or exercise your rights.

By clicking the button below, you agree to our processing of your personal information in accordance with the Privacy Policy, including sharing your personal information and transferring your personal information outside of China. If you do not agree, please do not use this website or provide your personal information to us.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options Manage services Manage {vendor_count} vendors Read more about these purposes

Accept Deny View preferences Save preferences View preferences

{title} {title} {title}

Manage consent

* English

* Chinese